See how medication is taken between two visits
DoryGo combines pre-sorted multi-dose blisters, a sensor pill box and a patient app. It records whether and when each dose is taken, so the conversation about intake can start from a record rather than from what the patient remembers.
Not a specialty clinic?
Same product, different entry point.
01 — The problem
Between two visits, the clinic sees nothing
In a specialty clinic, adherence is discussed at the consultation, and the only source is the patient. That captures what the patient remembers and chooses to report. It does not capture the weeks between visits, which is what a therapy's result depends on.
The only source is the patient
At the consultation, intake is what the patient recalls and is willing to say. It is an account, not a record.
A single value hides the course
A blood pressure or a lab value at the visit shows the result. It does not show the weeks of intake that led to it.
Non-response has two explanations
An insufficient effect and insufficient intake look the same at the consultation. Without a record of intake, the two cannot be told apart.
of plasma samples contained the study drug, while self-report and returned pill counts indicated 86–90% adherence (HIV prevention trial, women in South Africa, Uganda and Zimbabwe).
Source: Marrazzo et al., New England Journal of Medicine, 2015 (VOICE trial)
02 — Why it matters
Non-adherence is common, and its consequences reach the clinic
of patients in developed countries do not take medication for chronic conditions as prescribed.
of hospital admissions are associated with medication non-adherence (median across prospective studies).
higher odds of all-cause hospitalisation in non-adherent adults aged 50 and over.
Between two visits, a specialty clinic usually has no record of how its patients take their medication — only what they report at the next appointment. DoryGo adds that record: whether and when each dose was taken, collected passively at home and visible to your team in the dashboard. DoryGo records and displays intake; it does not interpret the data or recommend treatment.
We have not yet shown whether a reliable record of intake improves treatment results. That is the question we want to answer. A pilot is how we test it, together with a clinic that wants to know the answer as much as we do.
03 — The product
Three parts, one continuous record
Pre-sorted multi-dose blister
A pharmacy sorts the full regimen into dated, time-labelled compartments, so the patient never assembles a dose themselves.
- —One compartment per intake time, printed with date and patient name
- —Regimen changes handled at the pharmacy, not by the patient
- —Removes the manual weekly re-sorting step entirely
Sensor pill box
A new blister is inserted each day. The box registers each compartment opening passively — no app step, no confirmation, nothing else for the patient to remember.
- —Timestamped event per opening, at compartment level
- —Local buffering; syncs when a connection is available
- —Works for patients who do not use a smartphone
Patient app and dashboard
Patients see their own schedule and history. Your team sees recorded intake across all participating patients, sorted by missed and late doses.
- —Overview of all participating patients, sorted by missed and late doses
- —Intake history per patient
- —Role-based access; export via FHIR or CSV
04 — Workflow
From the pharmacy bench to your team, in five steps
05 — How step 1 is set up
Blistering runs through a licensed pharmacy partner in your market
There is one route, and it is deliberate. The pre-sorting is carried out by a local, licensed pharmacy partner, which we identify and set up together with your organisation. Dispensing stays where it is already regulated and already trusted. We equip that pharmacy with the sealing machine, the blisters and the foils, and we supply the box, the app, the dashboard and the integration.
National rules for dispensing, repackaging and medical-device classification differ, and they determine what is possible in your market. We clarify this per country before a pilot is scoped, and say so plainly where something is not viable.
06 — Evidence
What is shown, and what is not
Both columns are part of the same answer, and they carry the same weight. We would rather you take the right-hand column into your evaluation than discover it later.
What we can show today
- The box records each compartment opening without any patient input, which removes self-report bias by construction.
- The full chain is built and working end to end: blister, sensor box, patient app, dashboard.
- In our own development testing, compartment openings were detected without error over several months of continuous bench testing, and battery life reached 18 months at four openings per day. These are internal measurements; independent validation is planned.
What we have not shown yet
- Any effect on treatment results. Whether a reliable record of intake improves them is the question our pilots are designed to answer.
- A validated cost-offset figure for a specific insured population. We will not quote an ROI we cannot defend.
- Long-run persistence: how intake behaves after two years of use.
- Deployment at the scale of a full health system.
07 — Pilot
What a first project looks like
- Cohort
- Patients of one outpatient service on long-term medication, defined together with the treating physicians.
- Duration
- Pre-defined period of recording, plus a set-up and onboarding phase beforehand.
- What we measure
- Intake per dose and compartment, timing of each dose, data completeness and patient retention.
- What we provide
- Boxes, blister supply or partner coordination, patient onboarding material, dashboard access, and a named contact in Zurich.
- What we need from you
- A responsible physician, a data-protection contact, the cohort definition, and a team that looks at the intake record during the pilot.
- What you get
- A dataset you own, a written read-out with the limitations stated, and a clear basis for deciding whether to continue or stop.
08 — Integration
Into the systems you already run
09 — Compliance
Where the data sits, and who may see it
10 — About us
Who you would be working with
DoryHealth is a small Swiss company based in Zurich. We build and operate DoryGo ourselves, which means a pilot is run by the people who built the product rather than handed to an implementation team.
11 — Contact
Request a scoping call
Thirty minutes, no slide deck. We ask about your patient group and how your team works today, and tell you whether a pilot makes sense.
DoryHealth AG · Hagenholzstrasse 81a, 8050 Zürich
hello@doryhealth.com